Annual EBIT
-$103.00 M
+$32.40 M+23.93%
31 December 2023
Summary:
Passage Bio annual earnings before interest & taxes is currently -$103.00 million, with the most recent change of +$32.40 million (+23.93%) on 31 December 2023. During the last 3 years, it has risen by +$74.73 million (+42.05%). PASG annual EBIT is now -920.30% below its all-time high of -$10.10 million, reached on 31 December 2018.PASG EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$15.91 M
+$1.03 M+6.10%
30 September 2024
Summary:
Passage Bio quarterly earnings before interest & taxes is currently -$15.91 million, with the most recent change of +$1.03 million (+6.10%) on 30 September 2024. Over the past year, it has increased by +$2.54 million (+13.76%). PASG quarterly EBIT is now -279.91% below its all-time high of -$4.19 million, reached on 01 March 2019.PASG Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$69.34 M
+$7.38 M+9.61%
30 September 2024
Summary:
Passage Bio TTM earnings before interest & taxes is currently -$69.34 million, with the most recent change of +$7.38 million (+9.61%) on 30 September 2024. Over the past year, it has increased by +$33.66 million (+32.68%). PASG TTM EBIT is now -1556.15% below its all-time high of -$4.19 million, reached on 01 March 2019.PASG TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PASG EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | +13.8% | +32.7% |
3 y3 years | +42.0% | +68.3% | +61.0% |
5 y5 years | -180.7% | -17.0% | -89.0% |
PASG EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +42.0% | at high | +68.3% | at high | +61.8% |
5 y | 5 years | -180.7% | +42.0% | -17.0% | +68.3% | -89.0% | +61.8% |
alltime | all time | -920.3% | +42.0% | -279.9% | +68.3% | -1556.2% | +61.8% |
Passage Bio EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$15.91 M(-6.1%) | -$69.34 M(-9.6%) |
June 2024 | - | -$16.94 M(-6.1%) | -$76.72 M(-9.9%) |
Mar 2024 | - | -$18.05 M(-2.1%) | -$85.17 M(-17.3%) |
Dec 2023 | -$103.00 M(-23.9%) | -$18.45 M(-20.8%) | -$103.00 M(-8.7%) |
Sept 2023 | - | -$23.28 M(-8.3%) | -$112.80 M(-2.4%) |
June 2023 | - | -$25.39 M(-29.2%) | -$115.54 M(-11.1%) |
Mar 2023 | - | -$35.88 M(+27.0%) | -$129.97 M(-4.0%) |
Dec 2022 | -$135.39 M(-23.8%) | -$28.24 M(+8.5%) | -$135.39 M(-13.9%) |
Sept 2022 | - | -$26.03 M(-34.6%) | -$157.31 M(-9.0%) |
June 2022 | - | -$39.81 M(-3.6%) | -$172.88 M(-4.8%) |
Mar 2022 | - | -$41.31 M(-17.6%) | -$181.61 M(+2.2%) |
Dec 2021 | -$177.73 M | -$50.16 M(+20.6%) | -$177.73 M(+7.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2021 | - | -$41.60 M(-14.3%) | -$165.63 M(+8.5%) |
June 2021 | - | -$48.53 M(+29.7%) | -$152.65 M(+16.2%) |
Mar 2021 | - | -$37.43 M(-1.6%) | -$131.42 M(+17.4%) |
Dec 2020 | -$111.90 M(+205.0%) | -$38.06 M(+32.9%) | -$111.90 M(+28.0%) |
Sept 2020 | - | -$28.63 M(+4.9%) | -$87.44 M(+24.1%) |
June 2020 | - | -$27.30 M(+52.4%) | -$70.45 M(+39.7%) |
Mar 2020 | - | -$17.91 M(+31.8%) | -$50.41 M(+37.4%) |
Dec 2019 | -$36.69 M(+263.4%) | -$13.59 M(+16.7%) | -$36.69 M(+58.8%) |
Sept 2019 | - | -$11.64 M(+60.2%) | -$23.10 M(+101.7%) |
June 2019 | - | -$7.27 M(+73.6%) | -$11.45 M(+173.6%) |
Mar 2019 | - | -$4.19 M | -$4.19 M |
Dec 2018 | -$10.10 M | - | - |
FAQ
- What is Passage Bio annual earnings before interest & taxes?
- What is the all time high annual EBIT for Passage Bio?
- What is Passage Bio quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Passage Bio?
- What is Passage Bio quarterly EBIT year-on-year change?
- What is Passage Bio TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Passage Bio?
- What is Passage Bio TTM EBIT year-on-year change?
What is Passage Bio annual earnings before interest & taxes?
The current annual EBIT of PASG is -$103.00 M
What is the all time high annual EBIT for Passage Bio?
Passage Bio all-time high annual earnings before interest & taxes is -$10.10 M
What is Passage Bio quarterly earnings before interest & taxes?
The current quarterly EBIT of PASG is -$15.91 M
What is the all time high quarterly EBIT for Passage Bio?
Passage Bio all-time high quarterly earnings before interest & taxes is -$4.19 M
What is Passage Bio quarterly EBIT year-on-year change?
Over the past year, PASG quarterly earnings before interest & taxes has changed by +$2.54 M (+13.76%)
What is Passage Bio TTM earnings before interest & taxes?
The current TTM EBIT of PASG is -$69.34 M
What is the all time high TTM EBIT for Passage Bio?
Passage Bio all-time high TTM earnings before interest & taxes is -$4.19 M
What is Passage Bio TTM EBIT year-on-year change?
Over the past year, PASG TTM earnings before interest & taxes has changed by +$33.66 M (+32.68%)